Exact Mass: 335.013138

Exact Mass Matches: 335.013138

Found 102 metabolites which its exact mass value is equals to given mass value 335.013138, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Dihydroneopterin phosphate

[(2R,3S)-3-(2-amino-4-oxo-1,4,7,8-tetrahydropteridin-6-yl)-2,3-dihydroxypropoxy]phosphonic acid

C9H14N5O7P (335.06308240000004)

Dihydroneopterin phosphate is involved in the folate biosynthesis pathway. Dihydroneopterin phosphate is produced from 2-Amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)dihydropteridine. triphosphate by [E3.6.1.-]. Dihydroneopterin phosphate is then converted to Dihydroneopterin by [E3.6.1.-]. Dihydroneopterin phosphate is involved in the folate biosynthesis pathway. Dihydroneopterin phosphate is produced from 2-Amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)dihydropteridine

Zoxamide

Pesticide4_Zoxamide_C14H16Cl3NO2_3,5-Dichloro-N-(1-chloro-3-methyl-2-oxopentan-3-yl)-4-methylbenzamide

C14H16Cl3NO2 (335.0246566)

sulfanitran

C14H13N3O5S (335.0575888)

C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides

7,8-Dihydroneopterin 2-phosphate

C9H14N5O7P (335.06308240000004)

Nicotinate mononucleotide

nicotinic acid mononucleotide

C11H14NO9P (335.04061640000003)

Hapten A

3-{[methoxy(3-methyl-4-(methylsulfanyl)phenoxy)sulfanylidene-lambda5-phosphanyl]amino}propanoic acid

C12H18NO4PS2 (335.0414838)

isoxicam

4-hydroxy-2-methyl-N-(5-methyl-2,3-dihydro-1,2-oxazol-3-ylidene)-1,1-dioxo-2H-1λ⁶,2-benzothiazine-3-carboxamide

C14H13N3O5S (335.0575888)

C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

[(2R,3S,4R,5R)-5-(3-Carboxypyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl hydrogen phosphate

C11H14NO9P (335.04061640000003)

4-Amino-1,3-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid

4-Amino-1,3-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulphonic acid

C14H9NO7S (335.00997240000004)

2-Methyl-N-(5-methyl-3-isoxazolyl)-1,1,4-trioxo-3H-1$l^{6},2-benzothiazine-3-carboxamide

2-methyl-N-(5-methyl-1,2-oxazol-3-yl)-1,1,4-trioxo-3,4-dihydro-2H-1lambda6,2-benzothiazine-3-carboxamide

C14H13N3O5S (335.0575888)

S-sulfanylglutathione

[1-carboxylato-3-({1-[(carboxylatomethyl)carbamoyl]-2-disulfanylethyl}carbamoyl)propyl]azaniumyl

C10H13N3O6S2 (335.02457580000004)

S-sulfanylglutathione is a member of the class of compounds known as oligopeptides. Oligopeptides are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds. S-sulfanylglutathione is slightly soluble (in water) and a moderately acidic compound (based on its pKa). S-sulfanylglutathione can be found in a number of food items such as oil-seed camellia, apple, rapini, and angelica, which makes S-sulfanylglutathione a potential biomarker for the consumption of these food products.

isoxicam

C14H13N3O5S (335.0575888)

A monocarboxylic acid amide that is piroxicam in which the pyrid-2-yl group is replaced by a 5-methyl-1,2-oxazol-3-yl group. A non-steroidal anti-inflammatory drug, it was withdrawn from the market in the 1980s following its association with cases of Stevens-Johnson syndrome. C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

nicotinic acid mononucleotide

[(2R,3S,4R,5R)-5-(3-Carboxypyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl hydrogen phosphate

C11H14NO9P (335.04061640000003)

Acquisition and generation of the data is financially supported in part by CREST/JST.

MMV687243

C15H14NO3Br (335.0156994)

Deamido-NMN

3-carboxy-1-[(2R,3R,4S,5R)-5-[(hydrogen phosphonatooxy)methyl]-3,4-dihydroxyoxolan-2-yl]-2,3-dihydro-1$l^{5}-pyridin-1-ylium

C11H14NO9P (335.04061640000003)

CAY10443

(1S)-2,3-dihydro-1H-inden-1-yl ester [(3,4-dichlorophenyl)methyl]-carbamic acid

C17H15Cl2NO2 (335.047979)

Furosemide-d5

C12H6ClD5N2O5S (335.03910449000006)

5-(2,4-Dichlorophenyl)-3-(3-nitrophenyl)-1,2,4-oxadiazole

C14H7Cl2N3O3 (334.98644520000005)

(4-Bromophenyl)(4-trifluoromethylpiperidin-1-yl)methanone

C13H13BrF3NO (335.01325440000005)

6-(p-Toluidino)-2-naphthalenesulfonic acid sodium salt

C17H14NNaO3S (335.0592054)

Lobenzarit sodium

C14H8ClNNa2O4 (334.9937238)

C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

6-FLUORO-2-(3-(TRIFLUOROMETHYL)PHENYL)QUINOLINE-4-CARBOXYLIC ACID

C17H9F4NO2 (335.0569382)

8-FLUORO-2-(3-(TRIFLUOROMETHYL)PHENYL)QUINOLINE-4-CARBOXYLIC ACID

C17H9F4NO2 (335.0569382)

Fluorescent brightener 121

C15H14ClN3O2S (335.0495214)

N-(4-Bromophenyl)-1,1-diphenylmethanimine

C19H14BrN (335.03095440000004)

3-(6-IODO-IMIDAZO[1,2-A]PYRIDIN-2-YL)-PHENYLAMINE

C13H10IN3 (334.99194500000004)

2-chloro-4-nitrophenyl-beta-d-galactopyranoside

C12H14ClNO8 (335.0407914)

2-METHYL-3-ETHYL-6-METHOXY BENZOTHIAZOLIUM IODIDE

C11H14INOS (334.98408240000003)

1-[2,6-DICHLORO-4-(TRIFLUOROMETHYL)PHENYL]-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE

C14H10Cl2F3NO (335.00915060000005)

(+/-)-N,N-DIMETHYL-1-FERROCENYLETHYLAMINE

C16H18BrNO2 (335.0520828)

3-Bromo-9-(4-methylphenyl)-9H-carbazole

C19H14BrN (335.03095440000004)

4-[(3-Bromo-4-methoxyphenyl)sulfonyl]morpholine

C11H14BrNO4S (334.98268640000003)

4-[(5-Bromo-2-methoxyphenyl)sulfonyl]morpholine

C11H14BrNO4S (334.98268640000003)

4-AMINO-6-PHENYLPYRIMIDINE

C16H14ClNO5 (335.0560464)

8-BROMO-4-(METHYLTHIO)-7-PHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-AMINE

C12H10BrN5S (334.98402400000003)

3-[4-[(4-CHLOROPHENYL)THIO]-3-NITROPHENYL]ACRYLIC ACID

C15H10ClNO4S (335.001905)

7-Chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

C16H8ClF2NO3 (335.01607520000005)

4-BENZYL-5-(2,4-DICHLOROPHENYL)-4H-1,2,4-TRIAZOLE-3-THIOL

C15H11Cl2N3S (335.00507060000007)

3-carboxy-5-(4-chlorobenzoyl)-1,4-dimethyl-1H-pyrrole-2-acetic acid

C16H14ClNO5 (335.0560464)

2,4-diphenyl-1,3-thiazole-5-sulfonyl chloride

C15H10ClNO2S2 (334.984147)

(2R,3S,4S,5S,6R)-2-(2-CHLORO-4-NITROPHENOXY)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL

C12H14ClNO8 (335.0407914)

3-(2,4-dichlorophenyl)-4-(2-methylphenyl)-1H-1,2,4-triazole-5-thione

C15H11Cl2N3S (335.00507060000007)

5-BROMO-3-TERT-BUTOXYCARBONYLAMINO-THIOPHENE-2-CARBOXYLIC ACID METHYL ESTER

C11H14BrNO4S (334.98268640000003)

2-(2,4-Dichlorophenyl)-α-methyl-6-benzoxazoleacetic acid

C16H11Cl2NO3 (335.0115956000001)

2-Chloro-4-nitrophenyl α-D-glucopyranoside

C12H14ClNO8 (335.0407914)

3,4-Difluoro-N-(6-nitro-2-benzothiazolyl)benzamide

C14H7F2N3O3S (335.0176176)

3,5-bis(trifluoromethyl)benzenesulfonyl guanidine

C9H7F6N3O2S (335.0163154)

chlordiazepoxide hydrochloride

C16H15Cl2N3O (335.059212)

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

methyl 4-[2-hydroxyethyl(methyl)amino]-3-iodobenzoate

C11H14INO3 (335.0018404)

4-[3-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]benzenesulphonamide

C15H14ClN3O2S (335.0495214)

3-(5,6-dichloro-1H-indol-2-yl)-4-methoxybenzoic acid

C16H11Cl2NO3 (335.0115956000001)

tris(cyclopentadienyl)cerium

C15H15Ce (335.022811)

3-[2-[(4-CHLOROPHENYL)THIO]-5-NITROPHENYL]ACRYLIC ACID

C15H10ClNO4S (335.001905)

8-bromo-1-[(2S)-2-methoxypropyl]-3H-imidazo[4,5-c]quinolin-2-one

C14H14BrN3O2 (335.0269324)

9-benzyl-2-bromo-9H-carbazole

C19H14BrN (335.03095440000004)

methyl 2-bromo-3-cyclohexyl-1H-indole-6-carboxylate

C16H18BrNO2 (335.0520828)

2-dcamp sodium salt

C10H11N5NaO5P (335.0395486)

2-(Benzoyloxy)-N,N,N-trimethylethanaminium iodide

C12H18INO2 (335.0382238)

3-iodo-4-[(2-methoxyacetyl)amino]benzoic acid

C10H10INO4 (334.9654570000001)

4-[2-(Dimethylamino)ethoxy]-3-iodobenzoic acid

C11H14INO3 (335.0018404)

4-[[2-hydroxyethyl(methyl)amino]methyl]-3-iodobenzoic acid

C11H14INO3 (335.0018404)

5-Formyl-2-deoxy-cytidine-5-monophosphate

C10H14N3O8P (335.05184940000004)

Meclofenamate sodium

C14H12Cl2NNaO3 (335.00919020000003)

D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors